Showing results (41-50 of 5,223) with videos related to
Sort By:
Pageof 523
Current Pharmaceutical Design|March 2, 2011
Glycine transporter-1: a new potential therapeutic target for schizophreniaKenji HashimotoSeishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|June 28, 2011
[Development of new therapeutic drugs based on the pathophysiology of schizophrenia]Kenji HashimotoExperimental Neurology|January 14, 2015
Targeting the sigma-1 receptor chaperone in the treatment of perinatal brain injuryKenji HashimotoCentral Nervous System Agents in Medicinal Chemistry|December 22, 2009
Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationshipKenji HashimotoInternational Journal of Molecular Sciences|April 10, 2015
Inflammatory biomarkers as differential predictors of antidepressant responseKenji HashimotoExpert Opinion on Therapeutic Targets|November 18, 2014
Tropisetron and its targets in Alzheimer's diseaseKenji HashimotoFrontiers in Pharmacology|November 3, 2018
Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future PerspectiveKenji HashimotoRecent Patents on CNS Drug Discovery|January 29, 2008
Glycine transporter inhibitors as therapeutic agents for schizophreniaKenji HashimotoEuropean Archives of Psychiatry and Clinical Neuroscience|February 14, 2023
Arketamine for cognitive impairment in psychiatric disordersKenji HashimotoDiscover Mental Health|March 27, 2023
Overview of the potential use of fluvoxamine for COVID-19 and long COVIDKenji HashimotoPageof 523